GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.

Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections.

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk factors for TB treatment failure include ...

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

One-in-five cases of tuberculosis in Europe goes undetected, meaning tens of thousands of people never get treatment, the ...

Tuberculosis, also known as "the white plague," is rising in the U.S. post-pandemic, with over 10,600 cases confirmed in 2024, the CDC reports.

A medication developed in the 1950s to treat Parkinson's disease may offer a powerful new tool in the fight against tuberculosis (TB), according to new research from the University of British Columbia ...

Tuberculosis has been around for decades, and yet it refuses to loosen its grip on India. For a disease that is both ...

Tuberculosis remains a public health issue in Europe as the region is falling behind elimination targets, according to a new ...

Spinal tuberculosis, once a rare disease of older adults, is making its way into the lives of Gen Z. With subtle symptoms and ...

India faces a health emergency with drug-resistant TB, requiring urgent political commitment and holistic support for ...